Talk about your fuzzy math !

Posted on August 6, 2013 by Pharmaciststeve

Yesterday I posted about the CEO of CVS getting a 30% increase in pay as well as the stock holders getting a 30% increase in dividends  LET THEM EAT CAKE !

From recently released revenue statement from CVS… the company posted a ~ 20% gain in EPS ( earnings per share) … so how does the math work .. that a company has a 20% increase in profits and increases payouts to the CEO and stock holders by 30%… FUZZY MATH ??

http://investor.cvs.com/phoenix.zhtml?c=99533&p=irol-newsArticle&ID=1844878&highlight

CVS Caremark Reports Record Second Quarter Results

2013 GUIDANCE RANGE NARROWED PRIMARILY TO REFLECT TIMING OF SHARE REPURCHASES AND STRONG OPERATING RESULTS

WOONSOCKET, R.I., Aug. 6, 2013 /PRNewswire/ — CVS Caremark Corporation (NYSE: CVS) today announced operating results for the three months ended June 30, 2013.

Second Quarter Year-over-year Highlights:

  • Operating profit increased 15.2% to approximately $2.0 billion
  • Adjusted EPS increased 19.6% to $0.97; GAAP diluted EPS from continuing operations increased 20.8% to $0.91
  • Retail pharmacy same store prescription volumes increased 1.8%, or 5.0% on a 30-day equivalent basis
  • Retail pharmacy same store sales increased 0.8%; total same store sales increased 0.4%

Year-to-date Highlights: Generated free cash flow of $1.7 billion

  • Cash flow from operations of $2.5 billion

According to this website   https://eresearch.fidelity.com/eresearch/evaluate/fundamentals/ownership.jhtml?stockspage=insidertrends&symbols=CVS

Here are the top 10 insiders total stock holdings…  who are getting a 30% increase in dividends  WOO WHOO  !

RYAN, THOMAS M. Chairman 1,156,702.00 Disposition (Non Open Market) 04/03/11
MERLO, LARRY J. Chief Executive Officer 264,753.00 Acquisition (Non Open Market) 04/01/13
LOFBERG, PER G.H. President 217,454.00 Acquisition (Non Open Market) 02/19/13
RICKARD, DAVID B. Chief Financial Officer 207,179.00 Option Execute 12/14/09
PICCOLO, C.A. Director 181,461.00 Sell 12/14/12
MERLO, LARRY J. Chief Executive Officer 147,286.00 Option Execute 05/12/11
BROWN, C. DAVID II Director 141,252.00 Acquisition (Non Open Market) 11/08/12
ROSENBERG, SHELI Z. Director 125,112.00 Acquisition (Non Open Market) 11/04/10
MURRAY, TERRENCE Director 84,140.00 Acquisition (Non Open Market) 11/02/11
COSBY, MARK S. Principal 72,318.00 Acquisition (Non Open Market) 04/01/13

Filed under: General Problems

« »

Leave a Reply

Discover more from PHARMACIST STEVE

Subscribe now to keep reading and get access to the full archive.

Continue reading